APA (7th ed.) Citation

Q, O., R, J., R, Z., W, Q., X, L., L, C., . . . W, X. (2026). Denosumab in pediatric patients with fibrous dysplasia/McCune-Albright syndrome: A single-center, open-labeled study. Frontiers in endocrinology, 17, 1762370. https://doi.org/10.3389/fendo.2026.1762370

Chicago Style (17th ed.) Citation

Q, Ouyang, et al. "Denosumab in Pediatric Patients with Fibrous Dysplasia/McCune-Albright Syndrome: A Single-center, Open-labeled Study." Frontiers in Endocrinology 17 (2026): 1762370. https://doi.org/10.3389/fendo.2026.1762370.

MLA (9th ed.) Citation

Q, Ouyang, et al. "Denosumab in Pediatric Patients with Fibrous Dysplasia/McCune-Albright Syndrome: A Single-center, Open-labeled Study." Frontiers in Endocrinology, vol. 17, 2026, p. 1762370, https://doi.org/10.3389/fendo.2026.1762370.